Clinical trials
Glucose Metabolism Disorders trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 7 |
| 2007 | 1 |
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 8 |
| Eli Lilly and Company | 4 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Ultragenyx Pharmaceutical Inc | 2 |
| AstraZeneca | 1 |
| BiomeHub Biotechnology Company | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 19 |
| Diabetes Mellitus, Type 2 | 16 |
| Diabetes Mellitus | 15 |
| Metabolic Diseases | 9 |
| Dyslipidemias | 7 |
| Endocrine System Diseases | 7 |
| Glycogen Storage Disease Type I | 2 |
| Acute Coronary Syndrome | 1 |
| Body Weight | 1 |
| Diabetes Mellitus, Lipoatrophic | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.